Stat5 Promotes Survival of Mammary Epithelial Cells through Transcriptional Activation of a Distinct Promoter in Akt1

REFERENCES

• Aaronson, D. S., and C. M. Horvath. 2002. A road map for those who don't know JAK-STAT. Science 296:1653–1655.
   PubMed Web of Science ®Google Scholar
• Abell, K., A. Bilancio, R. W. Clarkson, P. G. Tiffen, A. I. Altaparmakov, T. G. Burdon, T. Asano, B. Vanhaesebroeck, and C. J. Watson. 2005. Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition. Nat. Cell Biol. 7:392–398.
   PubMedGoogle Scholar
• Abell, K., and C. J. Watson. 2005. The Jak/Stat pathway: a novel way to regulate PI3K activity. Cell Cycle 4:897–900.
   PubMed Web of Science ®Google Scholar
• Ackler, S., S. Ahmad, C. Tobias, M. D. Johnson, and R. I. Glazer. 2002. Delayed mammary gland involution in MMTV-AKT1 transgenic mice. Oncogene 21:198–206.
   PubMedGoogle Scholar
• Bailey, J. P., K. M. Nieport, M. P. Herbst, S. Srivastava, R. A. Serra, and N. D. Horseman. 2004. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway. Mol. Endocrinol. 18:1171–1184.
   PubMed Web of Science ®Google Scholar
• Bellacosa, A., T. F. Franke, M. E. Gonzalez-Portal, K. Datta, T. Taguchi, J. Gardner, J. Q. Cheng, J. R. Testa, and P. N. Tsichlis. 1993. Structure, expression and chromosomal mapping of c-Akt: relationship to v-Akt and its implications. Oncogene 8:745–754.
   PubMed Web of Science ®Google Scholar
• Bowe, D. B., N. J. Kenney, Y. Adereth, and I. G. Maroulakou. 2002. Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E. Oncogene 21:291–298.
   PubMed Web of Science ®Google Scholar
• Boxer, R. B., D. B. Stairs, K. D. Dugan, K. L. Notarfrancesco, C. P. Portocarrero, B. A. Keister, G. K. Belka, H. Cho, J. C. Rathmell, C. B. Thompson, M. J. Birnbaum, and L. A. Chodosh. 2006. Isoform-specific requirement for Akt1 in the developmental regulation of cellular metabolism during lactation. Cell Metab. 4:475–490.
   PubMedGoogle Scholar
• Brisken, C., A. Ayyannan, C. Nguyen, A. Heineman, F. Reinhardt, J. Tan, S. K. Dey, G. P. Dotto, R. A. Weinberg, and T. Jan. 2002. IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev. Cell 3:877–887.
   PubMed Web of Science ®Google Scholar
• Brockman, J. L., M. D. Schroeder, and L. A. Schuler. 2002. PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. Mol. Endocrinol. 16:774–784.
   PubMedGoogle Scholar
• Chapman, R. S., P. C. Lourenco, E. Tonner, D. J. Flint, S. Selbert, K. Takeda, S. Akira, A. R. Clarke, and C. J. Watson. 1999. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev. 13:2604–2616.
   PubMed Web of Science ®Google Scholar
• Chen, D., F. Mauvais-Jarvis, M. Bluher, S. J. Fisher, A. Jozsi, L. J. Goodyear, K. Ueki, and C. R. Kahn. 2004. p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity. Mol. Cell. Biol. 24:320–329.
   PubMedGoogle Scholar
• Clevenger, C. V., P. A. Furth, S. E. Hankinson, and L. A. Schuler. 2003. The role of prolactin in mammary carcinoma. Endocrinol. Rev. 24:1–27.
   PubMed Web of Science ®Google Scholar
• Cotarla, I., S. Ren, Y. Zhang, E. Gehan, B. Singh, and P. A. Furth. 2004. Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers. Int. J. Cancer 108:665–671.
   PubMed Web of Science ®Google Scholar
• Creamer, B. A., A. A. Triplett, and K. U. Wagner. 2009. Longitudinal analysis of mammogenesis using a novel tetracycline-inducible mouse model and in vivo imaging. Genesis 47:234–245.
   PubMedGoogle Scholar
• Cui, Y., G. Riedlinger, K. Miyoshi, W. Tang, C. Li, C. X. Deng, G. W. Robinson, and L. Hennighausen. 2004. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol. Cell. Biol. 24:8037–8047.
   PubMed Web of Science ®Google Scholar
• Diehl, J. A., M. Cheng, M. F. Roussel, and C. J. Sherr. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:3499–3511.
   PubMed Web of Science ®Google Scholar
• Eilon, T., B. Groner, and I. Barash. 2007. Tumors caused by overexpression and forced activation of Stat5 in mammary epithelial cells of transgenic mice are parity-dependent and developed in aged, postestropausal females. Int. J. Cancer 121:1892–1902.
   PubMedGoogle Scholar
• Fresno Vara, J. A., M. V. Carretero, H. Geronimo, K. Ballmer-Hofer, and J. Martin-Perez. 2000. Stimulation of c-Src by prolactin is independent of Jak2. Biochem. J. 345 (Pt. 1):17–24.
   PubMedGoogle Scholar
• Gourdou, I., J. Paly, C. Hue-Beauvais, L. Pessemesse, J. Clark, and J. Djiane. 2004. Expression by transgenesis of a constitutively active mutant form of the prolactin receptor induces premature abnormal development of the mouse mammary gland and lactation failure. Biol. Reprod. 70:718–728.
   PubMedGoogle Scholar
• Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57–70.
   PubMed Web of Science ®Google Scholar
• Hennighausen, L., and G. W. Robinson. 2005. Information networks in the mammary gland. Nat. Rev. Mol. Cell. Biol. 6:715–725.
   PubMedGoogle Scholar
• Humphreys, R. C., B. Bierie, L. Zhao, R. Raz, D. Levy, and L. Hennighausen. 2002. Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli. Endocrinology 143:3641–3650.
   PubMed Web of Science ®Google Scholar
• Humphreys, R. C., and L. Hennighausen. 1999. Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis. Cell Growth Differ. 10:685–694.
   PubMedGoogle Scholar
• Hutchinson, J., J. Jin, R. D. Cardiff, J. R. Woodgett, and W. J. Muller. 2001. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol. Cell. Biol. 21:2203–2212.
   PubMed Web of Science ®Google Scholar
• Hutchinson, J. N., J. Jin, R. D. Cardiff, J. R. Woodgett, and W. J. Muller. 2004. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res. 64:3171–3178.
   PubMed Web of Science ®Google Scholar
• Iavnilovitch, E., R. D. Cardiff, B. Groner, and I. Barash. 2004. Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice. Int. J. Cancer 112:607–619.
   PubMed Web of Science ®Google Scholar
• Iavnilovitch, E., B. Groner, and I. Barash. 2002. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis. Mol. Cancer Res. 1:32–47.
   PubMed Web of Science ®Google Scholar
• Ihle, J. N. 2001. The Stat family in cytokine signaling. Curr. Opin. Cell Biol. 13:211–217.
   PubMed Web of Science ®Google Scholar
• LeBaron, M. J., J. Xie, and H. Rui. 2005. Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer. Mol. Cancer 4:6–16.
   PubMedGoogle Scholar
• Li, M., X. Liu, G. Robinson, U. Bar-Peled, K. U. Wagner, W. S. Young, L. Hennighausen, and P. A. Furth. 1997. Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc. Natl. Acad. Sci. U. S. A. 94:3425–3430.
   PubMedGoogle Scholar
• Li, S., and J. M. Rosen. 1995. Nuclear factor I and mammary gland factor (STAT5) play a critical role in regulating rat whey acidic protein gene expression in transgenic mice. Mol. Cell. Biol. 15:2063–2070.
   PubMedGoogle Scholar
• Lin, D. I., M. D. Lessie, A. B. Gladden, C. H. Bassing, K. U. Wagner, and J. A. Diehl. 2008. Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis. Oncogene 27:1231–1242.
   PubMed Web of Science ®Google Scholar
• Lund, L. R., J. Romer, N. Thomasset, H. Solberg, C. Pyke, M. J. Bissell, K. Dano, and Z. Werb. 1996. Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 122:181–193.
   PubMed Web of Science ®Google Scholar
• Maroulakou, I. G., W. Oemler, S. P. Naber, I. Klebba, C. Kuperwasser, and P. N. Tsichlis. 2008. Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. J. Cell Physiol. 217:468–477.
   PubMed Web of Science ®Google Scholar
• Maroulakou, I. G., W. Oemler, S. P. Naber, and P. N. Tsichlis. 2007. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res. 67:167–177.
   PubMed Web of Science ®Google Scholar
• Miyoshi, K., J. M. Shillingford, G. H. Smith, S. L. Grimm, K. U. Wagner, T. Oka, J. M. Rosen, G. W. Robinson, and L. Hennighausen. 2001. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J. Cell Biol. 155:531–542.
   PubMed Web of Science ®Google Scholar
• Moriggl, R., V. Sexl, L. Kenner, C. Duntsch, K. Stangl, S. Gingras, A. Hoffmeyer, A. Bauer, R. Piekorz, D. Wang, K. D. Bunting, E. F. Wagner, K. Sonneck, P. Valent, J. N. Ihle, and H. Beug. 2005. Stat5 tetramer formation is associated with leukemogenesis. Cancer Cell 7:87–99.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay, S. S., S. L. Wyszomierski, R. M. Gronostajski, and J. M. Rosen. 2001. Differential interactions of specific nuclear factor I isoforms with the glucocorticoid receptor and STAT5 in the cooperative regulation of WAP gene transcription. Mol. Cell. Biol. 21:6859–6869.
   PubMedGoogle Scholar
• Nevalainen, M. T., J. Xie, J. Torhorst, L. Bubendorf, P. Haas, J. Kononen, G. Sauter, and H. Rui. 2004. Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J. Clin. Oncol. 22:2053–2060.
   PubMed Web of Science ®Google Scholar
• Ren, S., H. R. Cai, M. Li, and P. A. Furth. 2002. Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogene 21:4335–4339.
   PubMedGoogle Scholar
• Sakamoto, K., B. A. Creamer, A. A. Triplett, and K. U. Wagner. 2007. The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells. Mol. Endocrinol. 21:1877–1892.
   PubMedGoogle Scholar
• Sakamoto, K., W. C. Lin, A. A. Triplett, and K. U. Wagner. 2009. Targeting Janus kinase 2 in Her2/neu-expressing mammary cancer: implications for cancer prevention and therapy. Cancer Res. 69:6642–6650.
   PubMedGoogle Scholar
• Santos, S. C., V. Lacronique, I. Bouchaert, R. Monni, O. Bernard, S. Gisselbrecht, and F. Gouilleux. 2001. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway. Oncogene 20:2080–2090.
   PubMed Web of Science ®Google Scholar
• Schindler, C., and J. E. Darnell. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621–651.
   PubMed Web of Science ®Google Scholar
• Schwertfeger, K. L., M. M. Richert, and S. M. Anderson. 2001. Mammary gland involution is delayed by activated Akt in transgenic mice. Mol. Endocrinol. 15:867–881.
   PubMedGoogle Scholar
• Shillingford, J. M., K. Miyoshi, G. W. Robinson, S. L. Grimm, J. M. Rosen, H. Neubauer, K. Pfeffer, and L. Hennighausen. 2002. Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium. Mol. Endocrinol. 16:563–570.
   PubMed Web of Science ®Google Scholar
• Soldaini, E., S. John, S. Moro, J. Bollenbacher, U. Schindler, and W. J. Leonard. 2000. DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites. Mol. Cell. Biol. 20:389–401.
   PubMedGoogle Scholar
• Stocklin, E., M. Wissler, F. Gouilleux, and B. Groner. 1996. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383:726–728.
   PubMed Web of Science ®Google Scholar
• Wagner, K. U., A. Krempler, A. A. Triplett, Y. Qi, N. M. George, J. Zhu, and H. Rui. 2004. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Mol. Cell. Biol. 24:5510–5520.
   PubMed Web of Science ®Google Scholar
• Wagner, K. U., and G. H. Smith. 2005. Pregnancy and stem cell behavior. J. Mammary Gland Biol. Neoplasia 10:25–36.
   PubMedGoogle Scholar
• Watson, C. J., and K. Neoh. 2008. The Stat family of transcription factors have diverse roles in mammary gland development. Semin. Cell Dev. Biol. 19:401–406.
   PubMedGoogle Scholar
• Yamaji, D., R. Na, Y. Feuermann, S. Pechhold, W. Chen, G. W. Robinson, and L. Hennighausen. 2009. Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes Dev. 23:2382–2387.
   PubMedGoogle Scholar
• Yu, Q., Y. Geng, and P. Sicinski. 2001. Specific protection against breast cancers by cyclin D1 ablation. Nature 411:1017–1021.
   PubMed Web of Science ®Google Scholar